Neuroone Medical Technologies (NMTC) Retained Earnings (2016 - 2026)
Neuroone Medical Technologies filings provide 15 years of Retained Earnings readings, the most recent being -$82.1 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 8.74% to -$82.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$82.1 million, a 8.74% decrease, with the full-year FY2025 number at -$78.6 million, down 4.81% from a year prior.
- Retained Earnings hit -$82.1 million in Q1 2026 for Neuroone Medical Technologies, down from -$80.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$46.7 million in Q1 2022 to a low of -$82.1 million in Q1 2026.
- Median Retained Earnings over the past 5 years was -$68.9 million (2024), compared with a mean of -$66.2 million.
- Biggest five-year swings in Retained Earnings: plummeted 32.53% in 2022 and later decreased 4.81% in 2025.
- Neuroone Medical Technologies' Retained Earnings stood at -$52.6 million in 2022, then dropped by 25.57% to -$66.0 million in 2023, then decreased by 10.91% to -$73.2 million in 2024, then decreased by 9.35% to -$80.0 million in 2025, then fell by 2.56% to -$82.1 million in 2026.
- The last three reported values for Retained Earnings were -$82.1 million (Q1 2026), -$80.0 million (Q4 2025), and -$78.6 million (Q3 2025) per Business Quant data.